The move
As of Nov 16, CG Oncology (CGON) last traded around $84.00, up 12.9% on the session, on $410.7M of dollar volume, running about 3.0× its normal volume.
Why it is on our radar
Our radar flagged CGON for up 13%, heavy scanner alerts. It fired 38 of our alerts. On our nightly boards it shows up as a base breakout and a fresh 52-week high.
What the numbers show
Market cap is about $6.6B; short interest sits near 10% of shares outstanding, about 11.0 days to cover.
Insiders have made 1 open-market buy recently, officers backing the name with their own money.
The dilution picture
SEC filings flag a dilution risk here: At-the-market (ATM) offering active, the company can keep selling new shares into the market over time (ongoing). It is worth knowing before chasing a move, because new shares can cap a run.
The latest SEC filing
The most recent SEC filing on record is Material event (8-K) (Nov 16, 2026). Regulation FD Disclosure, Other Material Event
What to watch
On the chart, watch whether it holds its breakout level or fills back into its base.
How we built this
CGON was surfaced by our trending engine, which ranks stocks by real-time move, dollar volume, alert activity, and community chatter. The fundamentals, float, short interest, and filings come straight from our due-diligence data, sourced from SEC EDGAR. Nothing here is a fabricated stat, and nothing here is a recommendation.
Why is CGON moving?
CG Oncology is up on $410.7M of volume and ranks near the top of our trending board for up 13% and heavy scanner alerts. This reflects what our data shows as of Nov 16, not a forecast.
Is CGON heavily shorted?
Short interest in CGON is around 10% of its shares outstanding, roughly 11.0 days to cover, as of the most recent data we have.
Is this investment advice?
No. This is information and education built from public data, not investment advice, and we are not licensed financial advisors.